This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The $4,428.20 firm fixed-price delivery order has a completion date of December 23, 2024.
Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.
The contract award does not have a set-aside designation, indicating open competition. As a significant vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in supplying essential pharmaceutical and medical products to various government agencies.
Generated 3/21/25, 9:55 AM